Self‐Boosting Programmable Release of Multiple Therapeutic Agents by Activatable Heterodimeric Prodrug‐Enzyme Assembly for Antitumor Therapy
Advanced Science · 2025
DOI: 10.1002/advs.202409960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Shanshan Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Marshall Laboratory of Biomedical Engineering, International Cancer Center, Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imagi…. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Program, National Key R&D Program of China, Postdoctoral Fellowship Program of CPSF.
Abstract (Originalsprache)
Endogenous stimuli‐responsive prodrugs, due to their disease lesion specificity and reduced systemic toxicity, have been widely explored for antitumor therapy. However, reactive oxygen species (ROS) as classical endogenous stimuli in the tumor microenvironment (TME) are not enough to achieve the expected drug release. Herein, a ROS‐activatable heterodimeric prodrug‐loaded enzyme assembly is developed for self‐boosting programmable release of multiple therapeutic agents. The heterodimeric prodrug NBS‐TK‐PTX (namely NTP) is composed of 5‐(ethylamino)‐9‐diethylaminobenzo[ a ]phenothiazinium chloride analog (NBS), paclitaxel (PTX) and ROS‐responsive thioketal (TK) linker, which shows a strong binding affinity with glucose oxidase (GOx), thus obtaining NTP@GOx assembly. Notably, the enzymatic activity of GOx in NTP@GOx is inhibited by NTP. The programmable release is achieved by following steps: i) NTP@GOx is partially dissociated in acidic TME, thus releasing a small segment of NTP and GOx. Thereupon, the enzymatic activity of GOx is recovered; ii) GOx‐triggered pH reduction further facilitates the dissociation of NTP@GOx, thus accelerating a large amount of NTP and GOx release; iii) The TK linker of prodrug NTP is cleaved by hydrogen peroxide generated by GOx catalysis, thus expediting the release of NBS for Type‐I photodynamic therapy and PTX for chemotherapy, respectively. The NTP@GOx shows great potential for multimodal synergistic cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Marshall Laboratory of Biomedical Engineering, International Cancer Center, Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, Laboratory of Evolutionary Theranostics, School of Biomedical Engi…
- Nanophotonics Research Center, Shenzhen Key Laboratory of Micro-Scale Optical Information Technology, Institute of Microscale Optoelectronics, Shenzhen University, Shenzhen, 518060, China.
- Department of BioInterfaces, Institute for Chemistry and Bioanalytics, School of Life Sciences, FHNW University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, 4132, Switzerland.
ORCID-Profile: Jing Lin
Förderung
- Shenzhen Science and Technology Program
- National Key R&D Program of China
- Postdoctoral Fellowship Program of CPSF
- China Postdoctoral Science Foundation
- Shenzhen Medical Research Fund
- National Key Research and Development Program of China
Zitieren
APA
Jiang, S., Gurram, B., Zhu, J., Lei, S., Zhang, Y., He, T., Tagit, O., Fang, H., Huang, P., & Lin, J. (2025). Self‐Boosting Programmable Release of Multiple Therapeutic Agents by Activatable Heterodimeric Prodrug‐Enzyme Assembly for Antitumor Therapy. Advanced Science. https://doi.org/10.1002/advs.202409960
Vancouver
Jiang S, Gurram B, Zhu J, Lei S, Zhang Y, He T, et al. Self‐Boosting Programmable Release of Multiple Therapeutic Agents by Activatable Heterodimeric Prodrug‐Enzyme Assembly for Antitumor Therapy. Advanced Science. 2025. doi:10.1002/advs.202409960
BibTeX
@article{Jiang2025,
author = {Jiang, Shanshan and Gurram, Bhaskar and Zhu, Junfei and Lei, Shan and Zhang, Yifan and He, Ting and Tagit, Oya and Fang, Hui and Huang, Peng and Lin, Jing},
title = {Self‐Boosting Programmable Release of Multiple Therapeutic Agents by Activatable Heterodimeric Prodrug‐Enzyme Assembly for Antitumor Therapy},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202409960}
}
EUVIMED